Tobacco companies shaped ultra-processed foods. Now critics trying to reform the food landscape are working from the anti-tobacco playbook. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 7, 2026 Check out STAT+

Sponsored By

Ahead of the Super Bowl tomorrow, don't miss Alex Hogan's sneak peek of the pharma ads that will air during the big game and Damian Garde's analysis of how the ads run counter to the FDA's recent crackdown. Thanks for reading.

Camille MacMillin/STAT The push to turn Big Food into the new Big Tobacco RFK Jr. and his MAHA allies say food companies have made ultra-processed foods addictive. Food industry lobbyists call the claims inaccurate and risky By Sarah Todd Maria Fabrizo for STAT As male birth control gets closer to reality, men are lining up for clinical trials Men are signing up for clinical trials of new male birth control. Experts cite the Dobbs decision and desire to share burden of contraception By Annalisa Merelli Illustration: Camille MacMillin/STAT; Photos: Adobe STAT+ | Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer's  BMS faces a $20 billion annual revenue loss as its biggest drugs lose patent protection. It's counting heavily on an old drug's new use against Alzheimer's. By Damian Garde What to know about TrumpRx, the Trump administration's prescription drug platform Will TrumpRx accept insurance? Is TrumpRx open to all? Answers to frequently asked questions as White House unveils new portal that partners with GoodRx By Elaine Chen, John Wilkerson, and Chelsea Cirruzzo Opinion: I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life Pramipexole for restless leg syndrome and Parkinson's can cause compulsive behaviors. Doctors don't always warn patients. By J. Aaron Sanders STAT+ | AI could soon renew prescriptions without clinician help. Should the FDA make sure it's safe? As Utah pilots the use of AI for renewing drug prescriptions, experts ask if the technology should be regulated as a medical device. By Mario Aguilar What to know about Catherine O'Hara's rare heart condition, dextrocardia  Catherine O'Hara's heart and organs were on the wrong side of her body. Experts explain the rare condition called dextrocardia with situs inversus. By Elizabeth Cooney Fearing ICE crackdown, immigrants nationally are avoiding treatment, sometimes with dire consequences Patients, fearing arrest, wait longer for care or skip it. Doctors and health system leaders say the disruption poses a risk to public health. By Daniel Payne STAT+ | Vertex's CRISPR treatment for sickle cell disease hits unexpected roadblock Vertex's Casgevy can essentially cure sickle cell patients, but problems collecting stem cells are slowing uptake and threatening its edge. By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser